You are evaluating a Company and average remaining life of its PPE is say 8 years. As a Private Equiteer, you target investment period is say 4 years. This means, in your investment period, there will not be any significant CapEx.
And now you have a choice between 2 companies, both having average remaining lives of their PPE more than your investment horiozn. Comparing their EBITDA multiple to base your investment decision (as opposed to EBIT multiple) would be quite sensible, right?
My point is, if remaining life of PPE is LESS than your investment horizon, then you CANNOT ignore D&A, because D&A would add up to be part of your CapEx and an actual cash outflow, sometime within your investment horizon. But if remaining life of PPE is more than your investment horizon, you are using existing assets without any obligation of replacing them. So, you care more for EBITDA figure rather than EBIT.
And now you have a choice between 2 companies, both having average remaining lives of their PPE more than your investment horiozn. Comparing their EBITDA multiple to base your investment decision (as opposed to EBIT multiple) would be quite sensible, right?
My point is, if remaining life of PPE is LESS than your investment horizon, then you CANNOT ignore D&A, because D&A would add up to be part of your CapEx and an actual cash outflow, sometime within your investment horizon. But if remaining life of PPE is more than your investment horizon, you are using existing assets without any obligation of replacing them. So, you care more for EBITDA figure rather than EBIT.